New FDA Recommendations to Reduce the Risk of Transmission of Infectious Agents Associated with Sepsis

The FDA has issued new recommendations to reduce the risk of sepsis transmission through human cells, tissues, and tissue-derived products (HCT/Ps). The guidelines include rigorous donor screening, evaluation of clinical and physical evidence, and diagnostic testing to identify pathogens. The goal is to ensure the safety of tissue donation and protect public health.